nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—CYP2C9—brain cancer	0.612	1	CbGaD
Dopamine—CYP2D6—Lomustine—brain cancer	0.043	0.329	CbGbCtD
Dopamine—CYP1A2—Carmustine—brain cancer	0.0426	0.325	CbGbCtD
Dopamine—CYP2D6—Hydroxyurea—brain cancer	0.0326	0.249	CbGbCtD
Dopamine—CYP1A2—Etoposide—brain cancer	0.0126	0.0964	CbGbCtD
Dopamine—Gangrene—Hydroxyurea—brain cancer	0.00787	0.168	CcSEcCtD
Dopamine—DBH—cranial nerve—brain cancer	0.00739	0.0507	CbGeAlD
Dopamine—Azotaemia—Lomustine—brain cancer	0.00656	0.14	CcSEcCtD
Dopamine—DRD3—telencephalic ventricle—brain cancer	0.00493	0.0338	CbGeAlD
Dopamine—Extravasation—Carboplatin—brain cancer	0.00458	0.0976	CcSEcCtD
Dopamine—POU5F1—cerebellum—brain cancer	0.00423	0.029	CbGeAlD
Dopamine—DBH—ganglion—brain cancer	0.00374	0.0257	CbGeAlD
Dopamine—DRD1—telencephalic ventricle—brain cancer	0.00353	0.0242	CbGeAlD
Dopamine—HTR7—vein—brain cancer	0.00344	0.0236	CbGeAlD
Dopamine—COMT—telencephalic ventricle—brain cancer	0.00318	0.0218	CbGeAlD
Dopamine—DRD5—ganglion—brain cancer	0.00287	0.0197	CbGeAlD
Dopamine—DBH—hindbrain—brain cancer	0.00284	0.0195	CbGeAlD
Dopamine—SLC6A3—telencephalic ventricle—brain cancer	0.00284	0.0195	CbGeAlD
Dopamine—HTR7—cranial nerve—brain cancer	0.00271	0.0186	CbGeAlD
Dopamine—HTR7—pons—brain cancer	0.00268	0.0184	CbGeAlD
Dopamine—Azotaemia—Carmustine—brain cancer	0.00261	0.0555	CcSEcCtD
Dopamine—HTR1A—telencephalic ventricle—brain cancer	0.00231	0.0158	CbGeAlD
Dopamine—HTR7—telencephalic ventricle—brain cancer	0.0022	0.0151	CbGeAlD
Dopamine—DRD1—ganglion—brain cancer	0.0022	0.0151	CbGeAlD
Dopamine—DRD2—telencephalic ventricle—brain cancer	0.00208	0.0143	CbGeAlD
Dopamine—COMT—ganglion—brain cancer	0.00198	0.0136	CbGeAlD
Dopamine—Menorrhagia—Temozolomide—brain cancer	0.00181	0.0386	CcSEcCtD
Dopamine—Necrosis—Carmustine—brain cancer	0.00177	0.0377	CcSEcCtD
Dopamine—SLC6A3—ganglion—brain cancer	0.00177	0.0121	CbGeAlD
Dopamine—SLC22A1—ganglion—brain cancer	0.00174	0.0119	CbGeAlD
Dopamine—DBH—brainstem—brain cancer	0.00163	0.0112	CbGeAlD
Dopamine—SLC6A4—ganglion—brain cancer	0.00162	0.0111	CbGeAlD
Dopamine—Extravasation—Carmustine—brain cancer	0.00159	0.0339	CcSEcCtD
Dopamine—MAOB—ganglion—brain cancer	0.00154	0.0106	CbGeAlD
Dopamine—Cyanosis—Etoposide—brain cancer	0.00152	0.0323	CcSEcCtD
Dopamine—DBH—telencephalon—brain cancer	0.00144	0.00991	CbGeAlD
Dopamine—HTR1A—ganglion—brain cancer	0.00144	0.00986	CbGeAlD
Dopamine—SLC6A2—ganglion—brain cancer	0.00142	0.00978	CbGeAlD
Dopamine—HTR7—ganglion—brain cancer	0.00137	0.00943	CbGeAlD
Dopamine—Necrosis—Etoposide—brain cancer	0.00137	0.0291	CcSEcCtD
Dopamine—Angina pectoris—Procarbazine—brain cancer	0.00136	0.0289	CcSEcCtD
Dopamine—SLC6A3—hindbrain—brain cancer	0.00134	0.00919	CbGeAlD
Dopamine—MAOA—ganglion—brain cancer	0.00131	0.00901	CbGeAlD
Dopamine—DRD2—ganglion—brain cancer	0.0013	0.00891	CbGeAlD
Dopamine—Extravasation—Etoposide—brain cancer	0.00123	0.0262	CcSEcCtD
Dopamine—SLC6A4—hindbrain—brain cancer	0.00123	0.00842	CbGeAlD
Dopamine—HTR7—endothelium—brain cancer	0.00118	0.00813	CbGeAlD
Dopamine—MAOB—hindbrain—brain cancer	0.00117	0.00801	CbGeAlD
Dopamine—DBH—medulla oblongata—brain cancer	0.00113	0.00778	CbGeAlD
Dopamine—DRD5—telencephalon—brain cancer	0.00111	0.00762	CbGeAlD
Dopamine—HTR7—blood vessel—brain cancer	0.00109	0.00749	CbGeAlD
Dopamine—HTR1A—hindbrain—brain cancer	0.00109	0.00748	CbGeAlD
Dopamine—HTR7—hindbrain—brain cancer	0.00104	0.00715	CbGeAlD
Dopamine—MAOA—hindbrain—brain cancer	0.000995	0.00683	CbGeAlD
Dopamine—DRD2—hindbrain—brain cancer	0.000984	0.00676	CbGeAlD
Dopamine—DRD1—brainstem—brain cancer	0.000955	0.00656	CbGeAlD
Dopamine—DBH—endocrine gland—brain cancer	0.00091	0.00625	CbGeAlD
Dopamine—DBH—head—brain cancer	0.000898	0.00617	CbGeAlD
Dopamine—COMT—brainstem—brain cancer	0.000859	0.0059	CbGeAlD
Dopamine—DRD1—telencephalon—brain cancer	0.000847	0.00582	CbGeAlD
Dopamine—Hypertension—Procarbazine—brain cancer	0.000838	0.0178	CcSEcCtD
Dopamine—Anxiety—Procarbazine—brain cancer	0.000823	0.0175	CcSEcCtD
Dopamine—DBH—central nervous system—brain cancer	0.00082	0.00563	CbGeAlD
Dopamine—DBH—cerebellum—brain cancer	0.000801	0.0055	CbGeAlD
Dopamine—Vomiting—Lomustine—brain cancer	0.000793	0.0169	CcSEcCtD
Dopamine—Tachycardia—Procarbazine—brain cancer	0.000773	0.0165	CcSEcCtD
Dopamine—SLC6A3—brainstem—brain cancer	0.000767	0.00527	CbGeAlD
Dopamine—COMT—telencephalon—brain cancer	0.000762	0.00524	CbGeAlD
Dopamine—DRD4—brain—brain cancer	0.00076	0.00522	CbGeAlD
Dopamine—Nausea—Lomustine—brain cancer	0.000741	0.0158	CcSEcCtD
Dopamine—DRD3—head—brain cancer	0.000737	0.00506	CbGeAlD
Dopamine—SLC6A4—brainstem—brain cancer	0.000703	0.00483	CbGeAlD
Dopamine—DRD5—endocrine gland—brain cancer	0.000699	0.0048	CbGeAlD
Dopamine—DRD5—head—brain cancer	0.00069	0.00474	CbGeAlD
Dopamine—SLC6A3—telencephalon—brain cancer	0.000681	0.00468	CbGeAlD
Dopamine—DRD3—central nervous system—brain cancer	0.000673	0.00462	CbGeAlD
Dopamine—SLC22A1—telencephalon—brain cancer	0.000671	0.00461	CbGeAlD
Dopamine—MAOB—brainstem—brain cancer	0.000668	0.00459	CbGeAlD
Dopamine—DBH—brain—brain cancer	0.000651	0.00447	CbGeAlD
Dopamine—ADRB1—telencephalon—brain cancer	0.000646	0.00444	CbGeAlD
Dopamine—COMT—gonad—brain cancer	0.000636	0.00437	CbGeAlD
Dopamine—DRD5—central nervous system—brain cancer	0.00063	0.00433	CbGeAlD
Dopamine—HTR1A—brainstem—brain cancer	0.000624	0.00429	CbGeAlD
Dopamine—SLC6A4—telencephalon—brain cancer	0.000624	0.00428	CbGeAlD
Dopamine—COMT—pituitary gland—brain cancer	0.000621	0.00426	CbGeAlD
Dopamine—SLC6A2—brainstem—brain cancer	0.000619	0.00425	CbGeAlD
Dopamine—DRD1—midbrain—brain cancer	0.000608	0.00418	CbGeAlD
Dopamine—COMT—medulla oblongata—brain cancer	0.000599	0.00411	CbGeAlD
Dopamine—HTR7—brainstem—brain cancer	0.000597	0.0041	CbGeAlD
Dopamine—MAOB—telencephalon—brain cancer	0.000593	0.00407	CbGeAlD
Dopamine—CYP2D6—hindbrain—brain cancer	0.000591	0.00406	CbGeAlD
Dopamine—MAOA—brainstem—brain cancer	0.00057	0.00392	CbGeAlD
Dopamine—DRD2—brainstem—brain cancer	0.000564	0.00387	CbGeAlD
Dopamine—HTR1A—telencephalon—brain cancer	0.000554	0.0038	CbGeAlD
Dopamine—SLC6A2—telencephalon—brain cancer	0.000549	0.00377	CbGeAlD
Dopamine—COMT—midbrain—brain cancer	0.000548	0.00376	CbGeAlD
Dopamine—Dyspnoea—Hydroxyurea—brain cancer	0.000547	0.0116	CcSEcCtD
Dopamine—SLC22A3—gonad—brain cancer	0.000535	0.00367	CbGeAlD
Dopamine—COMT—spinal cord—brain cancer	0.000534	0.00367	CbGeAlD
Dopamine—DRD3—brain—brain cancer	0.000534	0.00367	CbGeAlD
Dopamine—HTR7—telencephalon—brain cancer	0.000529	0.00364	CbGeAlD
Dopamine—DRD1—head—brain cancer	0.000528	0.00362	CbGeAlD
Dopamine—Hypertension—Carmustine—brain cancer	0.000524	0.0112	CcSEcCtD
Dopamine—Palpitations—Temozolomide—brain cancer	0.000519	0.011	CcSEcCtD
Dopamine—Anxiety—Carmustine—brain cancer	0.000515	0.011	CcSEcCtD
Dopamine—Hypertension—Temozolomide—brain cancer	0.000507	0.0108	CcSEcCtD
Dopamine—MAOA—telencephalon—brain cancer	0.000506	0.00348	CbGeAlD
Dopamine—Vomiting—Procarbazine—brain cancer	0.000504	0.0107	CcSEcCtD
Dopamine—DRD2—telencephalon—brain cancer	0.000501	0.00344	CbGeAlD
Dopamine—DRD5—brain—brain cancer	0.0005	0.00344	CbGeAlD
Dopamine—Anxiety—Temozolomide—brain cancer	0.000498	0.0106	CcSEcCtD
Dopamine—Headache—Procarbazine—brain cancer	0.000496	0.0106	CcSEcCtD
Dopamine—SLC6A3—midbrain—brain cancer	0.000489	0.00336	CbGeAlD
Dopamine—Tachycardia—Carmustine—brain cancer	0.000484	0.0103	CcSEcCtD
Dopamine—MAOB—pituitary gland—brain cancer	0.000483	0.00332	CbGeAlD
Dopamine—DRD1—central nervous system—brain cancer	0.000482	0.00331	CbGeAlD
Dopamine—COMT—endocrine gland—brain cancer	0.000481	0.0033	CbGeAlD
Dopamine—SLC6A3—spinal cord—brain cancer	0.000477	0.00328	CbGeAlD
Dopamine—COMT—head—brain cancer	0.000475	0.00326	CbGeAlD
Dopamine—Nausea—Procarbazine—brain cancer	0.000471	0.01	CcSEcCtD
Dopamine—MAOB—medulla oblongata—brain cancer	0.000466	0.0032	CbGeAlD
Dopamine—SLC6A2—gonad—brain cancer	0.000458	0.00315	CbGeAlD
Dopamine—SLC6A4—midbrain—brain cancer	0.000448	0.00308	CbGeAlD
Dopamine—HTR7—gonad—brain cancer	0.000442	0.00303	CbGeAlD
Dopamine—Dyspnoea—Carmustine—brain cancer	0.000442	0.00941	CcSEcCtD
Dopamine—SLC6A4—spinal cord—brain cancer	0.000437	0.003	CbGeAlD
Dopamine—COMT—central nervous system—brain cancer	0.000433	0.00298	CbGeAlD
Dopamine—SLC6A2—medulla oblongata—brain cancer	0.000432	0.00296	CbGeAlD
Dopamine—Dyspnoea—Temozolomide—brain cancer	0.000427	0.00909	CcSEcCtD
Dopamine—MAOB—midbrain—brain cancer	0.000426	0.00293	CbGeAlD
Dopamine—SLC6A3—head—brain cancer	0.000424	0.00291	CbGeAlD
Dopamine—COMT—cerebellum—brain cancer	0.000424	0.00291	CbGeAlD
Dopamine—SLC22A1—endocrine gland—brain cancer	0.000423	0.00291	CbGeAlD
Dopamine—SLC22A1—head—brain cancer	0.000418	0.00287	CbGeAlD
Dopamine—HTR7—medulla oblongata—brain cancer	0.000416	0.00286	CbGeAlD
Dopamine—MAOB—spinal cord—brain cancer	0.000416	0.00285	CbGeAlD
Dopamine—MAOA—pituitary gland—brain cancer	0.000412	0.00283	CbGeAlD
Dopamine—DRD2—pituitary gland—brain cancer	0.000408	0.0028	CbGeAlD
Dopamine—ADRB1—endocrine gland—brain cancer	0.000407	0.0028	CbGeAlD
Dopamine—Hypertension—Etoposide—brain cancer	0.000405	0.00863	CcSEcCtD
Dopamine—SLC22A3—endocrine gland—brain cancer	0.000404	0.00278	CbGeAlD
Dopamine—ADRB1—head—brain cancer	0.000402	0.00276	CbGeAlD
Dopamine—SLC22A3—head—brain cancer	0.000399	0.00274	CbGeAlD
Dopamine—HTR1A—midbrain—brain cancer	0.000398	0.00273	CbGeAlD
Dopamine—MAOA—medulla oblongata—brain cancer	0.000398	0.00273	CbGeAlD
Dopamine—SLC6A4—endocrine gland—brain cancer	0.000394	0.0027	CbGeAlD
Dopamine—Vomiting—Hydroxyurea—brain cancer	0.00039	0.0083	CcSEcCtD
Dopamine—SLC6A4—head—brain cancer	0.000389	0.00267	CbGeAlD
Dopamine—HTR1A—spinal cord—brain cancer	0.000388	0.00267	CbGeAlD
Dopamine—SLC6A3—central nervous system—brain cancer	0.000387	0.00266	CbGeAlD
Dopamine—Headache—Hydroxyurea—brain cancer	0.000384	0.00818	CcSEcCtD
Dopamine—DRD1—brain—brain cancer	0.000382	0.00263	CbGeAlD
Dopamine—SLC22A1—central nervous system—brain cancer	0.000381	0.00262	CbGeAlD
Dopamine—HTR7—midbrain—brain cancer	0.00038	0.00261	CbGeAlD
Dopamine—SLC22A5—pituitary gland—brain cancer	0.00038	0.00261	CbGeAlD
Dopamine—SLC6A3—cerebellum—brain cancer	0.000378	0.0026	CbGeAlD
Dopamine—MAOB—endocrine gland—brain cancer	0.000374	0.00257	CbGeAlD
Dopamine—Tachycardia—Etoposide—brain cancer	0.000374	0.00797	CcSEcCtD
Dopamine—HTR7—spinal cord—brain cancer	0.000371	0.00255	CbGeAlD
Dopamine—MAOB—head—brain cancer	0.000369	0.00254	CbGeAlD
Dopamine—ADRB1—central nervous system—brain cancer	0.000367	0.00252	CbGeAlD
Dopamine—SLC22A5—medulla oblongata—brain cancer	0.000366	0.00252	CbGeAlD
Dopamine—SLC22A3—central nervous system—brain cancer	0.000364	0.0025	CbGeAlD
Dopamine—Nausea—Hydroxyurea—brain cancer	0.000364	0.00776	CcSEcCtD
Dopamine—MAOA—midbrain—brain cancer	0.000363	0.0025	CbGeAlD
Dopamine—DRD2—midbrain—brain cancer	0.000359	0.00247	CbGeAlD
Dopamine—SLC6A4—central nervous system—brain cancer	0.000355	0.00244	CbGeAlD
Dopamine—MAOA—spinal cord—brain cancer	0.000355	0.00244	CbGeAlD
Dopamine—HTR1A—endocrine gland—brain cancer	0.000349	0.0024	CbGeAlD
Dopamine—SLC6A2—endocrine gland—brain cancer	0.000346	0.00238	CbGeAlD
Dopamine—HTR1A—head—brain cancer	0.000345	0.00237	CbGeAlD
Dopamine—COMT—brain—brain cancer	0.000344	0.00236	CbGeAlD
Dopamine—SLC6A2—head—brain cancer	0.000342	0.00235	CbGeAlD
Dopamine—Dyspnoea—Etoposide—brain cancer	0.000342	0.00728	CcSEcCtD
Dopamine—CYP2D6—brainstem—brain cancer	0.000339	0.00233	CbGeAlD
Dopamine—MAOB—central nervous system—brain cancer	0.000337	0.00232	CbGeAlD
Dopamine—SLC22A5—midbrain—brain cancer	0.000335	0.0023	CbGeAlD
Dopamine—HTR7—endocrine gland—brain cancer	0.000334	0.00229	CbGeAlD
Dopamine—HTR7—head—brain cancer	0.00033	0.00226	CbGeAlD
Dopamine—MAOB—cerebellum—brain cancer	0.00033	0.00226	CbGeAlD
Dopamine—SLC22A5—spinal cord—brain cancer	0.000327	0.00224	CbGeAlD
Dopamine—CYP2C19—endocrine gland—brain cancer	0.000326	0.00224	CbGeAlD
Dopamine—MAOA—endocrine gland—brain cancer	0.000319	0.00219	CbGeAlD
Dopamine—DRD2—endocrine gland—brain cancer	0.000316	0.00217	CbGeAlD
Dopamine—MAOA—head—brain cancer	0.000315	0.00216	CbGeAlD
Dopamine—Vomiting—Carmustine—brain cancer	0.000315	0.00671	CcSEcCtD
Dopamine—HTR1A—central nervous system—brain cancer	0.000315	0.00216	CbGeAlD
Dopamine—SLC6A2—central nervous system—brain cancer	0.000312	0.00214	CbGeAlD
Dopamine—DRD2—head—brain cancer	0.000312	0.00214	CbGeAlD
Dopamine—Headache—Carmustine—brain cancer	0.00031	0.00661	CcSEcCtD
Dopamine—HTR1A—cerebellum—brain cancer	0.000308	0.00211	CbGeAlD
Dopamine—SLC6A3—brain—brain cancer	0.000307	0.00211	CbGeAlD
Dopamine—Vomiting—Temozolomide—brain cancer	0.000305	0.00649	CcSEcCtD
Dopamine—SLC22A1—brain—brain cancer	0.000303	0.00208	CbGeAlD
Dopamine—HTR7—central nervous system—brain cancer	0.000301	0.00207	CbGeAlD
Dopamine—CYP2D6—telencephalon—brain cancer	0.000301	0.00207	CbGeAlD
Dopamine—Headache—Temozolomide—brain cancer	0.0003	0.00639	CcSEcCtD
Dopamine—Nausea—Carmustine—brain cancer	0.000294	0.00627	CcSEcCtD
Dopamine—HTR7—cerebellum—brain cancer	0.000294	0.00202	CbGeAlD
Dopamine—ADRB1—brain—brain cancer	0.000291	0.002	CbGeAlD
Dopamine—SLC22A3—brain—brain cancer	0.000289	0.00199	CbGeAlD
Dopamine—MAOA—central nervous system—brain cancer	0.000288	0.00198	CbGeAlD
Dopamine—DRD2—central nervous system—brain cancer	0.000285	0.00195	CbGeAlD
Dopamine—Nausea—Temozolomide—brain cancer	0.000284	0.00606	CcSEcCtD
Dopamine—SLC6A4—brain—brain cancer	0.000282	0.00193	CbGeAlD
Dopamine—MAOA—cerebellum—brain cancer	0.000281	0.00193	CbGeAlD
Dopamine—DRD2—cerebellum—brain cancer	0.000278	0.00191	CbGeAlD
Dopamine—MAOB—brain—brain cancer	0.000268	0.00184	CbGeAlD
Dopamine—CYP1A2—endocrine gland—brain cancer	0.000266	0.00183	CbGeAlD
Dopamine—SLC22A5—cerebellum—brain cancer	0.000259	0.00178	CbGeAlD
Dopamine—CYP2C9—endocrine gland—brain cancer	0.000253	0.00174	CbGeAlD
Dopamine—HTR1A—brain—brain cancer	0.00025	0.00172	CbGeAlD
Dopamine—SLC6A2—brain—brain cancer	0.000248	0.0017	CbGeAlD
Dopamine—Vomiting—Etoposide—brain cancer	0.000244	0.00519	CcSEcCtD
Dopamine—Headache—Etoposide—brain cancer	0.00024	0.00511	CcSEcCtD
Dopamine—HTR7—brain—brain cancer	0.000239	0.00164	CbGeAlD
Dopamine—MAOA—brain—brain cancer	0.000228	0.00157	CbGeAlD
Dopamine—Nausea—Etoposide—brain cancer	0.000228	0.00485	CcSEcCtD
Dopamine—DRD2—brain—brain cancer	0.000226	0.00155	CbGeAlD
Dopamine—SLC22A5—brain—brain cancer	0.00021	0.00144	CbGeAlD
Dopamine—CYP2D6—endocrine gland—brain cancer	0.00019	0.0013	CbGeAlD
Dopamine—CYP2D6—head—brain cancer	0.000187	0.00129	CbGeAlD
Dopamine—CYP2D6—central nervous system—brain cancer	0.000171	0.00117	CbGeAlD
Dopamine—CYP2D6—cerebellum—brain cancer	0.000167	0.00115	CbGeAlD
Dopamine—CYP2D6—brain—brain cancer	0.000136	0.000932	CbGeAlD
Dopamine—HTR7—Signaling Pathways—SMO—brain cancer	2.27e-05	0.000354	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—VAV1—brain cancer	2.27e-05	0.000354	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GFAP—brain cancer	2.25e-05	0.00035	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VAV1—brain cancer	2.25e-05	0.00035	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HEY1—brain cancer	2.23e-05	0.000347	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TRPC6—brain cancer	2.21e-05	0.000345	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DLL1—brain cancer	2.18e-05	0.00034	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PTCH1—brain cancer	2.17e-05	0.000339	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SMO—brain cancer	2.17e-05	0.000339	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—VAV1—brain cancer	2.17e-05	0.000339	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GLI1—brain cancer	2.16e-05	0.000336	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HEY1—brain cancer	2.13e-05	0.000332	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ENO2—brain cancer	2.11e-05	0.000329	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—VAV1—brain cancer	2.1e-05	0.000327	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DLL1—brain cancer	2.09e-05	0.000326	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SHH—brain cancer	2.06e-05	0.000322	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—PIK3CG—brain cancer	2.05e-05	0.00032	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.05e-05	0.000319	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SUFU—brain cancer	2.04e-05	0.000319	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SHH—brain cancer	2.04e-05	0.000318	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—brain cancer	2e-05	0.000311	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TRPC6—brain cancer	1.99e-05	0.00031	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GFAP—brain cancer	1.97e-05	0.000308	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ENO2—brain cancer	1.97e-05	0.000307	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TRPC6—brain cancer	1.96e-05	0.000306	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—PIK3CG—brain cancer	1.96e-05	0.000306	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SMO—brain cancer	1.96e-05	0.000305	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTCH1—brain cancer	1.96e-05	0.000305	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SMO—brain cancer	1.93e-05	0.000301	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTCH1—brain cancer	1.93e-05	0.000301	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HES1—brain cancer	1.93e-05	0.000301	CbGpPWpGaD
Dopamine—COMT—Metabolism—PIK3CG—brain cancer	1.93e-05	0.0003	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—VAV1—brain cancer	1.91e-05	0.000297	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.88e-05	0.000293	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—IL2—brain cancer	1.87e-05	0.000292	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HEY1—brain cancer	1.87e-05	0.000292	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—PIK3CG—brain cancer	1.86e-05	0.00029	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SHH—brain cancer	1.86e-05	0.000289	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PDGFRA—brain cancer	1.84e-05	0.000287	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DLL1—brain cancer	1.83e-05	0.000286	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PIK3CG—brain cancer	1.83e-05	0.000285	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOTCH2—brain cancer	1.82e-05	0.000283	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TRPC6—brain cancer	1.79e-05	0.000279	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SPP1—brain cancer	1.78e-05	0.000278	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—PIK3CG—brain cancer	1.78e-05	0.000278	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SHH—brain cancer	1.78e-05	0.000277	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—PIK3CG—brain cancer	1.77e-05	0.000275	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SMO—brain cancer	1.76e-05	0.000274	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTCH1—brain cancer	1.76e-05	0.000274	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—PIK3CG—brain cancer	1.74e-05	0.000272	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—BSG—brain cancer	1.74e-05	0.000271	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOTCH2—brain cancer	1.74e-05	0.000271	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VAV1—brain cancer	1.73e-05	0.00027	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TRPC6—brain cancer	1.71e-05	0.000267	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL2—brain cancer	1.7e-05	0.000265	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTCH1—brain cancer	1.68e-05	0.000262	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SMO—brain cancer	1.68e-05	0.000262	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VAV1—brain cancer	1.66e-05	0.000258	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IRS2—brain cancer	1.61e-05	0.000252	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PIK3CG—brain cancer	1.6e-05	0.00025	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—BSG—brain cancer	1.6e-05	0.000249	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.59e-05	0.000249	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	1.59e-05	0.000248	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—BSG—brain cancer	1.59e-05	0.000247	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PIK3CG—brain cancer	1.58e-05	0.000247	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOTCH2—brain cancer	1.56e-05	0.000244	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SHH—brain cancer	1.56e-05	0.000243	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PIK3CG—brain cancer	1.55e-05	0.000241	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOTCH2—brain cancer	1.54e-05	0.000241	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	1.52e-05	0.000237	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TRPC6—brain cancer	1.5e-05	0.000234	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—IDH1—brain cancer	1.5e-05	0.000233	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VAV1—brain cancer	1.49e-05	0.000233	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HES1—brain cancer	1.49e-05	0.000232	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SMO—brain cancer	1.48e-05	0.00023	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTCH1—brain cancer	1.48e-05	0.00023	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VAV1—brain cancer	1.47e-05	0.00023	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—IL2—brain cancer	1.44e-05	0.000225	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	1.44e-05	0.000225	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—APC—brain cancer	1.43e-05	0.000222	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CG—brain cancer	1.43e-05	0.000222	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HES1—brain cancer	1.43e-05	0.000222	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PDGFRA—brain cancer	1.42e-05	0.000221	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOTCH2—brain cancer	1.41e-05	0.000219	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—IL2—brain cancer	1.38e-05	0.000215	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	1.38e-05	0.000215	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SPP1—brain cancer	1.38e-05	0.000215	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—IDH1—brain cancer	1.38e-05	0.000215	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—IDH1—brain cancer	1.36e-05	0.000213	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PDGFRA—brain cancer	1.36e-05	0.000212	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—BSG—brain cancer	1.36e-05	0.000211	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOTCH2—brain cancer	1.35e-05	0.00021	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VAV1—brain cancer	1.34e-05	0.000209	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	1.33e-05	0.000208	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SPP1—brain cancer	1.32e-05	0.000205	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL2—brain cancer	1.31e-05	0.000204	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—EGFR—brain cancer	1.3e-05	0.000203	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HES1—brain cancer	1.28e-05	0.0002	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VAV1—brain cancer	1.28e-05	0.0002	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HES1—brain cancer	1.27e-05	0.000197	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL2—brain cancer	1.25e-05	0.000195	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IRS2—brain cancer	1.24e-05	0.000194	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—IL2—brain cancer	1.24e-05	0.000194	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—IL2—brain cancer	1.23e-05	0.000191	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PDGFRA—brain cancer	1.22e-05	0.00019	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.22e-05	0.00019	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	1.21e-05	0.000189	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PDGFRA—brain cancer	1.21e-05	0.000188	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IRS2—brain cancer	1.19e-05	0.000186	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SPP1—brain cancer	1.19e-05	0.000185	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ENO2—brain cancer	1.18e-05	0.000184	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH2—brain cancer	1.18e-05	0.000184	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SPP1—brain cancer	1.17e-05	0.000182	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—IDH1—brain cancer	1.17e-05	0.000182	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HES1—brain cancer	1.15e-05	0.00018	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CG—brain cancer	1.15e-05	0.000179	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL2—brain cancer	1.13e-05	0.000176	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VAV1—brain cancer	1.13e-05	0.000176	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—IL2—brain cancer	1.12e-05	0.000174	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—RELA—brain cancer	1.11e-05	0.000174	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL2—brain cancer	1.11e-05	0.000174	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.11e-05	0.000173	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ERBB2—brain cancer	1.11e-05	0.000173	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HES1—brain cancer	1.1e-05	0.000172	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—APC—brain cancer	1.1e-05	0.000171	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CG—brain cancer	1.1e-05	0.000171	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PDGFRA—brain cancer	1.1e-05	0.000171	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ENO2—brain cancer	1.09e-05	0.00017	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ENO2—brain cancer	1.08e-05	0.000168	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IRS2—brain cancer	1.07e-05	0.000167	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.07e-05	0.000167	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SPP1—brain cancer	1.07e-05	0.000166	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IRS2—brain cancer	1.06e-05	0.000165	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000164	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—APC—brain cancer	1.05e-05	0.000164	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.05e-05	0.000164	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SPP1—brain cancer	1.02e-05	0.000159	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL2—brain cancer	1.01e-05	0.000158	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL2—brain cancer	1e-05	0.000156	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—EGFR—brain cancer	1e-05	0.000156	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCND1—brain cancer	9.78e-06	0.000153	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL2—brain cancer	9.7e-06	0.000151	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CG—brain cancer	9.69e-06	0.000151	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HES1—brain cancer	9.69e-06	0.000151	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CTNNB1—brain cancer	9.68e-06	0.000151	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IRS2—brain cancer	9.64e-06	0.00015	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—EGFR—brain cancer	9.59e-06	0.000149	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.49e-06	0.000148	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CG—brain cancer	9.47e-06	0.000148	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—APC—brain cancer	9.47e-06	0.000148	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—IL2—brain cancer	9.38e-06	0.000146	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—APC—brain cancer	9.35e-06	0.000146	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CG—brain cancer	9.35e-06	0.000146	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PDGFRA—brain cancer	9.22e-06	0.000144	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IRS2—brain cancer	9.22e-06	0.000144	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ENO2—brain cancer	9.21e-06	0.000144	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CG—brain cancer	9.03e-06	0.000141	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SPP1—brain cancer	8.95e-06	0.00014	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—EGFR—brain cancer	8.63e-06	0.000135	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—RELA—brain cancer	8.59e-06	0.000134	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ERBB2—brain cancer	8.53e-06	0.000133	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—brain cancer	8.53e-06	0.000133	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL2—brain cancer	8.52e-06	0.000133	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CG—brain cancer	8.52e-06	0.000133	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—APC—brain cancer	8.52e-06	0.000133	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—EGFR—brain cancer	8.51e-06	0.000133	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—STAT3—brain cancer	8.44e-06	0.000132	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—RELA—brain cancer	8.22e-06	0.000128	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ERBB2—brain cancer	8.17e-06	0.000127	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—APC—brain cancer	8.15e-06	0.000127	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	8.15e-06	0.000127	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IRS2—brain cancer	8.1e-06	0.000126	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—brain cancer	7.84e-06	0.000122	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—brain cancer	7.76e-06	0.000121	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL2—brain cancer	7.73e-06	0.000121	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—brain cancer	7.67e-06	0.00012	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCND1—brain cancer	7.54e-06	0.000118	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CTNNB1—brain cancer	7.47e-06	0.000116	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—brain cancer	7.42e-06	0.000116	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL2—brain cancer	7.4e-06	0.000115	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RELA—brain cancer	7.4e-06	0.000115	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB2—brain cancer	7.35e-06	0.000115	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RELA—brain cancer	7.3e-06	0.000114	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB2—brain cancer	7.26e-06	0.000113	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCND1—brain cancer	7.22e-06	0.000113	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CG—brain cancer	7.15e-06	0.000112	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APC—brain cancer	7.15e-06	0.000112	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CTNNB1—brain cancer	7.15e-06	0.000111	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2—brain cancer	6.67e-06	0.000104	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RELA—brain cancer	6.65e-06	0.000104	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB2—brain cancer	6.61e-06	0.000103	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2—brain cancer	6.58e-06	0.000103	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—brain cancer	6.57e-06	0.000103	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—brain cancer	6.52e-06	0.000102	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—brain cancer	6.51e-06	0.000101	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—brain cancer	6.5e-06	0.000101	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—brain cancer	6.44e-06	0.0001	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—brain cancer	6.43e-06	0.0001	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—brain cancer	6.41e-06	0.0001	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RELA—brain cancer	6.36e-06	9.92e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—brain cancer	6.35e-06	9.9e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—brain cancer	6.32e-06	9.86e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—brain cancer	6.29e-06	9.81e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—brain cancer	6.23e-06	9.72e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—brain cancer	6.05e-06	9.43e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—brain cancer	5.99e-06	9.34e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—brain cancer	5.92e-06	9.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—brain cancer	5.84e-06	9.11e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—brain cancer	5.79e-06	9.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—brain cancer	5.79e-06	9.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—brain cancer	5.73e-06	8.94e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—brain cancer	5.66e-06	8.83e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—brain cancer	5.66e-06	8.83e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—brain cancer	5.61e-06	8.75e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—brain cancer	5.59e-06	8.72e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RELA—brain cancer	5.59e-06	8.71e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—brain cancer	5.59e-06	8.71e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—brain cancer	5.55e-06	8.66e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—brain cancer	5.53e-06	8.63e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	5.53e-06	8.63e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.42e-06	8.46e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—brain cancer	5.21e-06	8.13e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—brain cancer	5.14e-06	8.02e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—brain cancer	5.1e-06	7.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—brain cancer	5.09e-06	7.94e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—brain cancer	5.04e-06	7.86e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—brain cancer	5.03e-06	7.85e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—brain cancer	5.03e-06	7.84e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.99e-06	7.78e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—brain cancer	4.97e-06	7.75e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.95e-06	7.71e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—brain cancer	4.91e-06	7.65e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—brain cancer	4.87e-06	7.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—brain cancer	4.86e-06	7.58e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—brain cancer	4.82e-06	7.52e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—brain cancer	4.75e-06	7.41e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—brain cancer	4.69e-06	7.31e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—brain cancer	4.58e-06	7.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—brain cancer	4.48e-06	6.99e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—brain cancer	4.38e-06	6.84e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—brain cancer	4.28e-06	6.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—brain cancer	4.28e-06	6.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—brain cancer	4.23e-06	6.6e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.23e-06	6.59e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—brain cancer	4.22e-06	6.59e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—brain cancer	3.94e-06	6.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—brain cancer	3.85e-06	6e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—brain cancer	3.85e-06	6e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—brain cancer	3.68e-06	5.74e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—brain cancer	3.23e-06	5.04e-05	CbGpPWpGaD
